Fact Sheet: Arguments against "Gateway to Smoking / Addiction" Claims ↗
From my GFN presentation in a panel titled "Debunking the Science Used to Support Prohibition"
24 July 2026
Dr. Arielle Selya is a behavioral science consultant specializing in tobacco harm reduction with over 80 scientific publications to date. Her primary role is Senior Scientist at Pinney Asociates, which consults to Juul Labs on tobacco harm reduction. She also consults as a scientific advisor to the Global Forum on Nicotine. Prior to her consulting roles, she spent a decade in academia studying adolescent nicotine use. Dr. Selya's public engagement on science on social media and Substack is her own content and is not commissioned, funded, or overseen by her employers or clients.
From my GFN presentation in a panel titled "Debunking the Science Used to Support Prohibition"
24 July 2026
From my GFN presentation in a panel titled "Debunking the Science Used to Support Prohibition"
16 July 2026
Adapted from my GFN 2026 presentation
10 July 2026
My take on an exchange about Beaglehole et al.'s article showing a sudden steeper decline in New Zealand's smoking rate. Below, I expand my PubPeer comment on a published criticism to this article.
3 July 2026
My new paper shows that US adults are in the midst of switching from combustible cigarettes to e-cigarette use, with little dual use. Many other countries show similar transitions.
25 June 2026
Laura Leigh Oyler (Haypp Group) and I discuss the history and current events of US regulation of nicotine and tobacco products.
14 June 2026
These are the trains of thought going through my head when I receive peer review invitations. Other scientists, what do you do?
4 May 2026
With wider acceptance that e-cigarettes are a viable harm-reduction method among people who smoke, the scientific battleground has retreated to "dual use." A recent exchange captures this well.
24 April 2026
Copied below is an email that my collaborators and I sent to journal editors expressing concern about a recent paper claiming a link between e-cigarette use and chronic kidney disease
8 April 2026
Five reasons why a prescription-only model is problematic (video & text)
23 March 2026
Highlights, lowlights, and other notable things from the conference. Not meant to be an all-inclusive list or a representative summary; just what stood out to me personally.
12 March 2026
A highly-criticized meta-analysis of e-cigs &health outcomes was just updated. Not only does it still perpetuate critical flaws in the underlying studies, but it's interpreted with double-standards.
21 February 2026
In my weekly review of new nicotine/tobacco research, I just saw two examples of a critical flaw that to my knowledge is a brand new error. (The two papers have a common author.)
14 February 2026
Efforts to correct flawed science often go nowhere, but there are a few recent successes: a couple post-publication criticisms and a retraction - though not before flawed papers had caused real damage
26 January 2026
I’ve decided to create a personal YouTube channel as part of a New Year’s resolution to bring THR science more widely to the public.
16 January 2026
How I went from academic tobacco control researcher to industry consultant after changing my mind with my own analyses
7 January 2026
Observational behavioral studies cannot inform about causality, let alone make recommendations about effective policy. Yet many such logical leaps routinely get through peer review.
28 December 2025
Lifestyle-related behaviors are important determinants of health — but excessive focus on potential risks is undermining people's autonomy to make the most basic decisions on their own.
20 December 2025
The near-exclusive focus on extrinsic (and ignoring of intrinsic) drivers of behavior
9 November 2025
How it can improve research integrity, where it can go wrong, and how to do it right
3 November 2025